The major histocompatibility complex and autism spectrum disorder

Developmental Neurobiology

Volumn 72, Issue 10, 2012, Pages 1288-1301

  Needleman, Leigh A ^a,b   Mcallister, A Kimberley ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Genetics; Maternal infection; Neuroimmunology; Synapse formation; Synaptic plasticity

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 3;

ARTICLE; AUTISM; BRAIN DEVELOPMENT; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; GENE MUTATION; HUMAN; IMMUNE DYSREGULATION; IMMUNE FUNCTION TEST; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GENE-ENVIRONMENT INTERACTION; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84865850000     PISSN: 19328451     EISSN: 10974695     Source Type: Journal    
DOI: 10.1002/dneu.22046     Document Type: Article

References (143)

1. Abdallah MW, Larsen N, Grove J, Norgaard-Pedersen B, Thorsen P, Mortensen EL, et al. Amniotic fluid inflammatory cytokines: Potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry, doi: 10.3109/15622975.2011.639803.
2. Abdallah MW, Larsen N, Grove J, Norgaard-Pedersen B, Thorsen P, Mortensen EL, Hougaard DM. 2012. Amniotic fluid chemokines and autism spectrum disorders: An exploratory study utilizing a Danish Historic Birth Cohort. Brain Behav Immun 26: 170-176.
3. Albensi BC, Mattson MP. 2000. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35: 151-159.
4. Alfonso C, Karlsson L. 2000. Nonclassical MHC class II molecules. Ann Rev Immunol 18: 113-142.
5. Ashwood P, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen RL, Croen LA, Ozonoff S, et al. 2008. Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment inclinical behavioral outcomes. J Neuroimmunol 204: 149-153.
6. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J. 2011a. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol 232: 196-199.
7. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J. 2011b. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun 25: 40-45.
8. Ashwood P, Kwong C, Hansen R, Hertz-Picciotto I, Croen L, Krakowiak P, Walker W, et al. 2008. Brief report: Plasma leptin levels are elevated in autism: Association with early onset phenotype? J Autism Dev Disord 38: 169-175.
9. Atladottir HO, Thorsen P, Ostergaard L, Schendel DE, Lemcke S, Abdallah M, Parner ET. 2010. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40: 1423-1430.
10. Bauer S, Kerr BJ, Patterson PH. 2007. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 8: 221-232.
11. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, et al. 2002. Control of synaptic strength by glial TNFalpha. Science 295: 2282-2285.
12. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S, Moran JL, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry, doi: 10.1038/mp.2012.73.
13. Bhat R, Steinman L. 2009. Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64: 123-132.
14. Boulanger LM. 2009. Immune proteins in brain development and synaptic plasticity. Neuron 64: 93-109.
15. Boulanger LM, Shatz CJ. 2004. Immune signalling in neural development, synaptic plasticity and disease. Nat Rev Neurosci 5: 521-531.
16. Brown AS. 2012. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol, 72: 1272-1276.
17. Brown AS, Patterson PH. 2011. Maternal infection and schizophrenia: Implications for prevention. Schizophr Bull 37: 284-290.
18. Careaga M, Van de Water J, Ashwood P. 2010. Immune dysfunction in autism: A pathway to treatment. Neurotherapeutics 7: 283-292.
19. Chess S. 1977. Follow-up report on autism in congenital rubella. J Autism Child Schizophr 7: 69-81.
20. Chez MG, Dowling T, Patel PB, Khanna P, Kominsky M. 2007. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr Neurol 36: 361-365.
21. Corbett BA, Kantor AB, Schulman H, Walker WL, Lit L, Ashwood P, Rocke DM, et al. 2007. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry 12: 292-306.
22. Corriveau RA, Huh GS, Shatz CJ. 1998. Regulation of class I MHC gene expression in the developing and mature CNS by neural activity. Neuron 21: 505-520.
23. Daniels WW, Warren RP, Odell JD, Maciulis A, Burger RA, Warren WL, Torres AR. 1995. Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology 32: 120-123.
24. Datwani A, McConnell MJ, Kanold PO, Micheva KD, Busse B, Shamloo M, Smith SJ, et al. 2009. Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron 64: 463-470.
25. Davies BJ, Pickard BS, Steel M, Morris RG, Lathe R. 1998. Serine proteases in rodent hippocampus. J Biol Chem 273: 23004-23011.
26. Deverman BE, Patterson PH. 2009. Cytokines and CNS development. Neuron 64: 61-78.
27. Deykin EY, MacMahon B. 1979. Viral exposure and autism. Am J Epidemiol 109: 628-638.
28. Enstrom AM, Onore CE, Van de Water JA, Ashwood P. 2010. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 24: 64-71.
29. Enstrom AM, Van de Water JA, Ashwood P. 2009. Autoimmunity in autism. Curr Opin Investig Drugs 10: 463-473.
30. Fatemi SH, Emamian ES, Sidwell RW, Kist DA, Stary JM, Earle JA, Thuras P. 2002. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7: 633-640.
31. Fatemi SH, Sidwell R, Kist D, Akhter P, Meltzer HY, Bailey K, Thuras P, et al. 1998. Differential expression of synaptosome-associated protein 25 kDa [SNAP-25] in hippocampi of neonatal mice following exposure to human influenza virus in utero. Brain Res 800: 1-9.
32. Ferrante P, Saresella M, Guerini FR, Marzorati M, Musetti MC, Cazzullo AG. 2003. Significant association of HLA A2-DR11 with CD4 naive decrease in autistic children. Biomed Pharmacother 57: 372-374.
33. Foster J, Brown I. 1996. Basal expression of stress-inducible hsp70 mRNA detected in hippocampal and cortical neurons of normal rabbit brain. Brain Res 724: 73-83.
34. Fourgeaud L, Boulanger LM. 2010. Role of immune molecules in the establishment and plasticity of glutamatergic synapses. Eur J Neurosci 32: 207-217.
35. Fourgeaud L, Davenport CM, Tyler CM, Cheng TT, Spencer MB, Boulanger LM. 2010. MHC class I modulates NMDA receptor function and AMPA receptor trafficking. Proc Natl Acad Sci USA 107: 22278-22283.
36. Garay PA, McAllister AK. 2010. Novel roles for immune molecules in neural development: Implications for neurodevelopmental disorders. Front Synaptic Neurosci 2: 136.
37. Gejman PV, Sanders AR, Kendler KS. 2011. Genetics of schizophrenia: New findings and challenges. Annu Rev Genomics Hum Genet 12: 121-144.
38. Geschwind DH. 2011. Genetics of autism spectrum disorders. Trends Cogn Sci 15: 409-416.
39. Glynn MW, Elmer BM, Garay PA, Liu XB, Needleman LA, El-Sabeawy F, McAllister AK. 2011. MHCI negatively regulates synapse density during the establishment of cortical connections. Nat Neurosci 14: 442-451.
40. Goddard CA, Butts DA, Shatz CJ. 2007. Regulation of CNS synapses by neuronal MHC class I. Proc Natl Acad Sci USA 104: 6828-6833.
41. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J, Hansen R, Kharrazi M, et al. 2011. Increased midgestational IFN-gamma, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism 2: 13.
42. Goldsmith CA, Rogers DP. 2008. The case for autoimmunity in the etiology of schizophrenia. Pharmacotherapy 28: 730-741.
43. Guerini FR, Bolognesi E, Chiappedi M, De Silvestri A, Ghezzo A, Zanette M, Rusconi B, et al. 2011. HLA polymorphisms in Italian children with autism spectrum disorders: Results of a family based linkage study. J Neuroimmunol 230: 135-142.
44. Guerini FR, Bolognesi E, Manca S, Sotgiu S, Zanzottera M, Agliardi C, Usai S, et al. 2009. Family-based transmission analysis of HLA genetic markers in Sardinian children with autistic spectrum disorders. Hum Immunol 70: 184-190.
45. Guerini FR, Manca S, Sotgiu S, Tremolada S, Zanzottera M, Agliardi C, Zanetta L, et al. 2006. A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder. Hum Immunol 67: 108-117.
46. Haga S, Aizawa T, Ishii T, Ikeda K. 1996. Complement gene expression in mouse microglia and astrocytes in culture: Comparisons with mouse peritoneal macrophages. Neurosci Lett 216: 191-194.
47. Hagberg H, Gressens P, Mallard C. 2012. Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 71: 444-457.
48. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, Miller J, et al. 2011. Genetic Heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68: 1095-1102.
49. Hamshere ML, Walters JT, Smith R, Richards AL, Green E, Grozeva D, Jones I, et al. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol Psychiatry, doi: 10.1038/mp.2012.67.
50. Hsiao EY, Patterson PH. 2011. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 25: 604-615.
51. Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ. 2000. Functional requirement for class I MHC in CNS development and plasticity. Science 290: 2155-2159.
52. Janeway CA, Travers P, Walport M, Shlomchik M. 2004. Immunobiology. Oxford, UK: Garland Science.
53. Jia P, Wang L, Fanous AH, Chen X, Kendler KS, Zhao Z. 2012. A bias-reducing pathway enrichment analysis of genome-wide association data confirmed association of the MHC region with schizophrenia. J Med Genet 49: 96-103.
54. Johnson WG, Buyske S, Mars AE, Sreenath M, Stenroos ES, Williams TA, Stein R, et al. 2009. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch Pediatr Adolesc Med 163: 542-546.
55. Kanner L. 1943. Autistic disturbances of affective contact. Nervous Child 2: 217-250.
56. Kinney DK, Munir KM, Crowley DJ, Miller AM. 2008. Prenatal stress and risk for autism. Neurosci Biobehav Rev 32: 1519-1532.
57. Kipnis J, Derecki NC, Yang C, Scrable H. 2008. Immunity and cognition: What do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol 29: 455-463.
58. Krzewski K, Strominger JL. 2008. The killer's kiss: The many functions of NK cell immunological synapses. Curr Opin Cell Biol 20: 597-605.
59. Lee LC, Zachary AA, Leffell MS, Newschaffer CJ, Matteson KJ, Tyler JD, Zimmerman AW. 2006. HLA-DR4 in families with autism. Pediatr Neurol 35: 303-307.
60. Lee RH, Mills EA, Schwartz N, Bell MR, Deeg KE, Ruthazer ES, Marsh-Armstrong N, et al. 2010. Neurodevelopmental effects of chronic exposure to elevated levels of pro-inflammatory cytokines in a developing visual system. Neural Dev 5: 2.
61. Li WX. 2008. Canonical and non-canonical JAK-STAT signaling. Trends Cell Biol 18: 545-551.
62. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. 2005. Autistic disorder and viral infections. J Neurovirol 11: 1-10.
63. Long EO. 2008. Negative signaling by inhibitory receptors: The NK cell paradigm. Immunol Rev 224: 70-84.
64. Luber-Narod J, Rogers J. 1988. Immune system associated antigens expressed by cells of the human central nervous system. Neurosci Lett 94: 17-22.
65. Machold RP, Ploegh HL. 1996. Intermediates in the assembly and degradation of class I major histocompatibility complex (MHC) molecules probed with free heavy chain-specific monoclonal antibodies. J Exp Med 184: 2251-2259.
66. Malkova NV, Yu CZ, Hsiao EY, Patterson PH. 2012. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav Immun 26: 607-616.
67. Manzardo AM, Henkhaus R, Dhillon S, Butler MG. 2011. Plasma cytokine levels in children with autistic disorder and unrelated siblings. Int J Dev Neurosci 30: 121-127.
68. McAllister AK, van de Water J. 2009. Breaking boundaries in neural-immune interactions. Neuron 64: 9-12.
69. McConnell MJ, Huang YH, Datwani A, Shatz CJ. 2009. H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. Proc Natl Acad Sci USA 106: 6784-6789.
70. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
71. Meyer U, Feldon J. 2010. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 90: 285-326.
72. Meyer U, Feldon J, Dammann O. 2011. Schizophrenia and autism: Both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 69: 26R-33R.
73. Meyer U, Nyffeler M, Engler A, Urwyler A, Schedlowski M, Knuesel I, Yee BK, et al. 2006. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26: 4752-4762.
74. Meyer U, Nyffeler M, Yee BK, Knuesel I, Feldon J. 2008. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22: 469-486.
75. Michel M, Schmidt MJ, Mirnics K. 2012. Immune system gene dysregulation in autism and schizophrenia. Dev Neurobiol 72: 1277-1287.
76. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P, Altaye M, et al. 2006. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172: 198-205.
77. Mostafa GA, Shehab AA. 2010. The link of C4B null allele to autism and to a family history of autoimmunity in Egyptian autistic children. J Neuroimmunol 223: 115-119.
78. Needleman LA, Liu XB, El-Sabeawy F, Jones EG, McAllister AK. 2010. MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood. Proc Natl Acad Sci USA 107: 16999-17004.
79. Neefjes J, Jongsma ML, Paul P, Bakke O. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11: 823-836.
80. Neumann H, Schmidt H, Cavalie A, Jenne D, Wekerle H. 1997. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: Differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J Exp Med 185: 305-316.
81. Nordahl CW, Lange N, Li DD, Barnett LA, Lee A, Buonocore MH, Simon TJ, et al. 2011. Brain enlargement is associated with regression in preschool-age boys with autism spectrum disorders. Proc Natl Acad Sci USA 108: 20195-20200.
82. Odell D, Maciulis A, Cutler A, Warren L, McMahon WM, Coon H, Stubbs G, et al. 2005. Confirmation of the association of the C4B null allelle in autism. Hum Immunol 66: 140-145.
83. Onore C, Careaga M, Ashwood P. 2011. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun.
84. Onore C, Enstrom A, Krakowiak P, Hertz-Picciotto I, Hansen R, Van de Water J, Ashwood P. 2009. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol 216: 126-129.
85. Patterson PH. 2009. Immune involvement in schizophrenia and autism: Etiology, pathology and animal models. Behav Brain Res 204: 313-321.
86. Patterson PH. 2011. Maternal infection and immune involvement in autism. Trends Mol Med 17: 389-394.
87. Patterson PH. 2011. Modeling autistic features in animals. Pediatr Res 69: 34R-40R.
88. Perlmutter LS, Scott SA, Barron E, Chui HC. 1992. MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J Neurosci Res 33: 549-558.
89. Peudenier S, Hery C, Ng KH, Tardieu M. 1991. HIV receptors within the brain: A study of CD4 and MHC-II on human neurons, astrocytes and microglial cells. Res Virol 142: 145-149.
90. Plioplys AV, Greaves A, Kazemi K, Silverman E. 1994. Lymphocyte function in autism and Rett syndrome. Neuropsychobiology 29: 12-16.
91. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752.
92. Reichelt AC, Rodgers RJ, Clapcote SJ. 2012. The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology 62: 1519-1526.
93. Rezaie P, Male D. 1999. Colonisation of the developing human brain and spinal cord by microglia: A review. Microsc Res Tech 45: 359-382.
94. Ribic A, Zhang M, Schlumbohm C, Matz-Rensing K, Uchanska-Ziegler B, Flugge G, Zhang W, et al. 2010. Neuronal MHC class I molecules are involved in excitatory synaptic transmission at the hippocampal mossy fiber synapses of marmoset monkeys. Cell Mol Neurobiol 30: 827-839.
95. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. 2009. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med 163: 907-914.
96. Santos SG, Powis SJ, Arosa FA. 2004. Misfolding of major histocompatibility complex class I molecules in activated T cells allows cis-interactions with receptors and signaling molecules and is associated with tyrosine phosphorylation. J Biol Chem 279: 53062-53070.
97. Schafer DP, Stevens B. 2010. Synapse elimination during development and disease: Immune molecules take centre stage. Biochem Soc Trans 38: 476-481.
98. Schindler C, Levy DE, Decker T. 2007. JAK-STAT signaling: From interferons to cytokines. J Biol Chem 282: 20059-20063.
99. Shatz CJ. 2009. MHC class I: An unexpected role in neuronal plasticity. Neuron 64: 40-45.
100. Shelton JF, Tancredi DJ, Hertz-Picciotto I. 2010. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res 3: 30-39.
101. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, et al. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757.
102. Shi L, Fatemi SH, Sidwell RW, Patterson PH. 2003. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23: 297-302.
103. Shi L, Smith SE, Malkova N, Tse D, Su Y, Patterson PH. 2009. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 23: 116-123.
104. Singh VK, Warren R, Averett R, Ghaziuddin M. 1997. Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatr Neurol 17: 88-90.
105. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. 2007. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27: 10695-10702.
106. Song WC. 2006. Complement regulatory proteins and autoimmunity. Autoimmunity 39: 403-410.
107. Spiliotis ET, Pentcheva T, Edidin M. 2002. Probing for membrane domains in the endoplasmic reticulum: Retention and degradation of unassembled MHC class I molecules. Mol Biol Cell 13: 1566-1581.
108. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, et al. 2009. Common variants conferring risk of schizophrenia. Nature 460: 744-747.
109. Stellwagen D. 2011. The contribution of TNFalpha to synaptic plasticity and nervous system function. Adv Exp Med Biol 691: 541-557.
110. Stellwagen D, Beattie EC, Seo JY, Malenka RC. 2005. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25: 3219-3228.
111. Stellwagen D, Malenka RC. 2006. Synaptic scaling mediated by glial TNF-alpha. Nature 440: 1054-1059.
112. Stetler RA, Gan Y, Zhang W, Liou AK, Gao Y, Cao G, Chen J. 2010. Heat shock proteins: Cellular and molecular mechanisms in the central nervous system. Prog Neurobiol 92: 184-211.
113. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, et al. 2007. The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164-1178.
114. Stubbs EG. 1978. Autistic symptoms in a child with congenital cytomegalovirus infection. J Autism Child Schizophr 8: 37-43.
115. Stubbs EG, Magenis RE. 1980. HLA and autism. J Autism Dev Disord 10: 15-19.
116. Stubbs EG, Ritvo ER, Mason-Brothers A. 1985. Autism and shared parental HLA antigens. J Am Acad Child Psychiatry 24: 182-185.
117. Stubbs G. 1981. Shared parental HLA antigens and autism. Lancet 2: 534.
118. Sweeten TL, Posey DJ, McDougle CJ. 2004. Brief report: Autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 34: 583-586.
119. Syken J, Grandpre T, Kanold PO, Shatz CJ. 2006. PirB restricts ocular-dominance plasticity in visual cortex. Science 313: 1795-1800.
120. Szatmari P. 2011. Is autism, at least in part, a disorder of fetal programming? Arch Gen Psychiatry 68: 1091-1092.
121. Tancredi V, D'Antuono M, Cafe C, Giovedi S, Bue MC, D'Arcangelo G, Onofri F, et al. 2000. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J Neurochem 75: 634-643.
122. Thomas A, Gasque P, Vaudry D, Gonzalez B, Fontaine M. 2000. Expression of a complete and functional complement system by human neuronal cells in vitro. Int Immunol 12: 1015-1023.
123. Torres AR, Maciulis A, Stubbs EG, Cutler A, Odell D. 2002. The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum Immunol 63: 311-316.
124. Torres AR, Sweeten TL, Cutler A, Bedke BJ, Fillmore M, Stubbs EG, Odell D. 2006. The association and linkage of the HLA-A2 class I allele with autism. Hum Immunol 67: 346-351.
125. Traynor TR, Majde JA, Bohnet SG, Krueger JM. 2004. Intratracheal double-stranded RNA plus interferon-gamma: A model for analysis of the acute phase response to respiratory viral infections. Life Sci 74: 2563-2576.
126. Turner T, Pihur V, Chakravarti A. 2011. Quantifying and modeling birth order effects in autism. PLoS One 6: e26418.
127. Turturici G, Sconzo G, Geraci F. 2011. Hsp70 and its molecular role in nervous system diseases. Biochem Res Int 2011: 618127.
128. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57: 67-81.
129. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, Mill J, et al. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474: 380-384.
130. Walker DG, Kim SU, McGeer PL. 1998. Expression of complement C4 and C9 genes by human astrocytes. Brain Res 809: 31-38.
131. Warren RP, Burger RA, Odell D, Torres AR, Warren WL. 1994. Decreased plasma concentrations of the C4B complement protein in autism. Arch Pediatr Adolesc Med 148: 180-183.
132. Warren RP, Cole P, Odell JD, Pingree CB, Warren WL, White E, Yonk J, et al. 1990. Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry 29: 873-877.
133. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW, Torres AR. 1996. Strong association of the third hypervariable region of HLA-DR beta 1 with autism. J Neuroimmunol 67: 97-102.
134. Warren RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL, DeWitt CW, et al. 1992. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 36: 203-207.
135. Warren RP, Singh VK, Cole P, Odell JD, Pingree CB, Warren WL, White E. 1991. Increased frequency of the null allele at the complement C4b locus in autism. Clin Exp Immunol 83: 438-440.
136. Wierzba-Bobrowicz T, Kosno-Kruszewska E, Lewandowska E, Lechowicz W, Schmidt-Sidor B. 2001. Major histocompatibility complex class II (MHC II) expression during development of human fetal brain and haemopoietic organs. Adv Exp Med Biol 495: 93-101.
137. Williams DB, Barber BH, Flavell RA, Allen H. 1989. Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J Immunol 142: 2796-2806.
138. Wingate M, Mulvihill B, Kirby R, Pettygrove S, Cunniff C, Meaney F, Schulz E, et al. 2012. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61: 1-19.
139. Xu HP, Chen H, Ding Q, Xie ZH, Chen L, Diao L, Wang P, et al. 2010. The immune protein CD3zeta is required for normal development of neural circuits in the retina. Neuron 65: 503-515.
140. Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T. 2003. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord 33: 455-459.
141. Yenari MA. 2002. Heat shock proteins and neuroprotection. Adv Exp Med Biol 513: 281-299.
142. Zerbo O, Iosif AM, Delwiche L, Walker C, Hertz-Picciotto I. 2011. Month of conception and risk of autism. Epidemiology 22: 469-475.
143. Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ. 2008. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease. J Neurochem 106: 2080-2092.